- $16.76bn
- $26.18bn
- $15.94bn
- 72
- 78
- 80
- 90
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 14,909 | 12,691 | 14,684 | 14,222 | 15,941 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,265 | 13,643 | 12,130 | 12,753 | 13,693 |
Operating Profit | 1,644 | -952 | 2,554 | 1,469 | 2,248 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,119 | -1,464 | 2,160 | 1,114 | 1,996 |
Provision for Income Taxes | |||||
Net Income After Taxes | 871 | -1,291 | 1,685 | 891 | 1,545 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 932 | -931 | 1,562 | 822 | 1,434 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 932 | -931 | 1,562 | 822 | 1,434 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.64 | 0.006 | 6.1 | 4.48 | 7.29 |
Dividends per Share |